These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 36426933)

  • 1. The roles and mechanisms of circular RNAs related to mTOR in cancers.
    Cao C; Wang Y; Wu X; Li Z; Guo J; Sun W
    J Clin Lab Anal; 2022 Dec; 36(12):e24783. PubMed ID: 36426933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The circular RNA hsa-circ-0072309 plays anti-tumour roles by sponging miR-100 through the deactivation of PI3K/AKT and mTOR pathways in the renal carcinoma cell lines.
    Chen T; Shao S; Li W; Liu Y; Cao Y
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3638-3648. PubMed ID: 31456425
    [No Abstract]   [Full Text] [Related]  

  • 3. Circular RNA hsa_circ_0010882 promotes the progression of gastric cancer via regulation of the PI3K/Akt/mTOR signaling pathway.
    Peng YK; Pu K; Su HX; Zhang J; Zheng Y; Ji R; Guo QH; Wang YP; Guan QL; Zhou YN
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1142-1151. PubMed ID: 32096170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel potential tumor biomarkers: Circular RNAs and exosomal circular RNAs in gastrointestinal malignancies.
    Wang Y; Li Z; Xu S; Guo J
    J Clin Lab Anal; 2020 Jul; 34(7):e23359. PubMed ID: 32419229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hsa_circ_0000199 facilitates chemo-tolerance of triple-negative breast cancer by interfering with miR-206/613-led PI3K/Akt/mTOR signaling.
    Li H; Xu W; Xia Z; Liu W; Pan G; Ding J; Li J; Wang J; Xie X; Jiang D
    Aging (Albany NY); 2021 Jan; 13(3):4522-4551. PubMed ID: 33495420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. hsa_circ_0006168 sponges miR-100 and regulates mTOR to promote the proliferation, migration and invasion of esophageal squamous cell carcinoma.
    Shi Y; Guo Z; Fang N; Jiang W; Fan Y; He Y; Ma Z; Chen Y
    Biomed Pharmacother; 2019 Sep; 117():109151. PubMed ID: 31229921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circular RNA hsa_circ_0011324 is involved in endometrial cancer progression and the evolution of its mechanism.
    Liu D; Bi X; Yang Y
    Bioengineered; 2022 Mar; 13(3):7485-7499. PubMed ID: 35259044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hsa_circ_0001495 contributes to cervical cancer progression by targeting miR-526b-3p/TMBIM6/mTOR axis.
    Zhang X; Zheng X
    Reprod Biol; 2022 Jun; 22(2):100648. PubMed ID: 35533615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The biogenesis and biological functions of circular RNAs and their molecular diagnostic values in cancers.
    Zhang H; Shen Y; Li Z; Ruan Y; Li T; Xiao B; Sun W
    J Clin Lab Anal; 2020 Jan; 34(1):e23049. PubMed ID: 31556152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The depletion of Circ-PRKDC enhances autophagy and apoptosis in T-cell acute lymphoblastic leukemia via microRNA-653-5p/Reelin mediation of the PI3K/AKT/mTOR signaling pathway.
    Ling Z; Fang ZG; Wu JY; Liu JJ
    Kaohsiung J Med Sci; 2021 May; 37(5):392-401. PubMed ID: 33615686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpressing circular RNA hsa_circ_0002052 impairs osteosarcoma progression via inhibiting Wnt/β-catenin pathway by regulating miR-1205/APC2 axis.
    Wu Z; Shi W; Jiang C
    Biochem Biophys Res Commun; 2018 Aug; 502(4):465-471. PubMed ID: 29852168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-suppressive circular RNAs: Mechanisms underlying their suppression of tumor occurrence and use as therapeutic targets.
    Li Z; Ruan Y; Zhang H; Shen Y; Li T; Xiao B
    Cancer Sci; 2019 Dec; 110(12):3630-3638. PubMed ID: 31599076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circular RNA circMBOAT2 promotes prostate cancer progression via a miR-1271-5p/mTOR axis.
    Shi J; Liu C; Chen C; Guo K; Tang Z; Luo Y; Chen L; Su Y; Xu K
    Aging (Albany NY); 2020 Jul; 12(13):13255-13280. PubMed ID: 32645691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of circular RNA hsa_circ_0001649 indicates poor prognosis for retinoblastoma and regulates cell proliferation and apoptosis via AKT/mTOR signaling pathway.
    Xing L; Zhang L; Feng Y; Cui Z; Ding L
    Biomed Pharmacother; 2018 Sep; 105():326-333. PubMed ID: 29864621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circular RNAs hsa_circ_0032462, hsa_circ_0028173, hsa_circ_0005909 are predicted to promote CADM1 expression by functioning as miRNAs sponge in human osteosarcoma.
    Chen G; Wang Q; Yang Q; Li Z; Du Z; Ren M; Zhao H; Song Y; Zhang G
    PLoS One; 2018; 13(8):e0202896. PubMed ID: 30153287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circular RNA hsa_circ_0072309 inhibits the proliferation, invasion and migration of gastric cancer cells via inhibition of PI3K/AKT signaling by activating PPARγ/PTEN signaling.
    Guo X; Qin M; Hong H; Xue X; Fang J; Jiang L; Kuang Y; Gao L
    Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CircRNA hsa_circ_0002577 accelerates endometrial cancer progression through activating IGF1R/PI3K/Akt pathway.
    Wang Y; Yin L; Sun X
    J Exp Clin Cancer Res; 2020 Aug; 39(1):169. PubMed ID: 32847606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hsa_circ_001569 is an unfavorable prognostic factor and promotes cell proliferation and metastasis by modulating PI3K-AKT pathway in breast cancer.
    Xu JH; Wang Y; Xu D
    Cancer Biomark; 2019; 25(2):193-201. PubMed ID: 31104012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hsa_circ_0003732 promotes osteosarcoma cells proliferation via miR-545/CCNA2 axis.
    Li L; Kong XA; Zang M; Dong J; Feng Y; Gui B; Hu Y
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32537647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulated hsa_circ_0077837 and hsa_circ_0004826, facilitate bladder cancer progression and predict poor prognosis for bladder cancer patients.
    Shen C; Wu Z; Wang Y; Gao S; Da L; Xie L; Qie Y; Tian D; Hu H
    Cancer Med; 2020 Jun; 9(11):3885-3903. PubMed ID: 32250047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.